Molecular portraits of cell cycle checkpoint kinases in cancer evolution, progression, and treatment responsiveness

Elena Oropeza1,2, Sinem Seker1,2, Sabrina Carrel1,2

  • 1Aging and Cancer Immunology, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA.

Science Advances
|June 30, 2023
PubMed

Insights

The way cell cycle checkpoints are disrupted impacts breast cancer characteristics. Different disruptions influence cancer subtype, metastasis, and treatment response, suggesting new diagnostic approaches.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Cell cycle dysregulation is fundamental to cancer development.
  • The specific mechanisms of cell cycle dysregulation and their impact on cancer characteristics remain unclear.

Purpose of the Study:

  • To investigate how different modes of cell cycle checkpoint dysregulation influence the characteristics of estrogen receptor-positive/human epidermal growth factor receptor 2-negative (ER+/HER2-) breast cancer.
  • To determine if the mode of cell cycle dysregulation affects cancer subtype, metastatic potential, and treatment resistance.

Main Methods:

  • Comprehensive analysis of patient data.
  • Experimental investigations.
  • Statistical analysis of mutation enrichment and survival data.

Main Results:

  • ATM mutations are linked to primary ER+/HER2- cancer in older women.
  • CHK2 dysregulation is associated with metastatic, treatment-resistant ER+/HER2- breast cancer in premenopausal women.
  • ATR/TP53 co-mutation is enriched in ER+/HER2- disease and promotes metastatic progression, with ATR dysregulation inducing metastatic phenotypes in TP53 mutant cells.

Conclusions:

  • The mode of cell cycle dysregulation is a critical determinant of breast cancer subtype, metastatic potential, and therapeutic responsiveness.
  • Findings suggest reconsidering cancer diagnostics based on the specific mechanisms of cell cycle dysregulation.

Related Concept Videos

Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
5.5K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.5K
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
5.6K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.4K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
The Cell Cycle Control System01:28

The Cell Cycle Control System

The cell cycle regulation directs how a cell proceeds from one phase to the next and begins mitosis. The cell cycle control system includes intracellular regulatory molecules and external triggers. They provide "stop" or "advance" signals and operate at specific cell cycle stages termed checkpoints to ensure that a particular process is completed before the cell advances to the next phase.
Cyclins and cyclin-dependent kinases (Cdks) are the primary cell cycle regulators and...
3.1K